Initially an experimental drug, Tysabri now appears to have approval as a disease-modifying treatment for Multiple Sclerosis
The marketing of Tysabri was suspended after two deaths were linked to the drug. This decision has since been reversed.
A diagnosis of MS will inevitably lead to a plethora of questions. Here, we try to address the most common multiple sclerosis FAQ.
Sadly, as so little is understood about the development of MS, many questions do not yet have answers.
Alison Peebles has been diagnosed with MS but, as a busy actress/director she has chosen to conceal this fact from family and friends.
She has MS, but hasn’t told anyone, not even her mother. Alison has kept her condition secret as she fears a backlash! She may not get any work, her friends may desert her.
Taggart star Alison Peebles is fighting her MS with the help of spine manipulation treatment from her physiotherapist friend Chongsu Lee
The technique involves manipulation of the spine and surrounding soft tissue to release tension from the body, allowing better movements of the neck, shoulders and back. As tension around the spine gradually eases off, blood and lymph circulation and the nerve function improve.
Advanced Cell Therapeutics (ACT) have issued a statement defending their position on using stem cell replacement therapies
This statement was issued to refute claims made in a BBC documentary about immoral and possibly illegal clinical therapies being undertaken by this company.
Epitol, Novartis and Tegretol are all brand names for Carbamazepine a pain reliever and an anticonvulsant agent used in treating such disorders as Trigeminal Neuralgia in Multiple Sclerosis, Epilepsy and Mania Disorders.
Carbamazepine is not an ordinary pain killer and should always be taken under direction from your physician. It is likely that the doctor will monitor your condition while under treatment to ensure no adverse reaction to the drug.
An Alzheimer’s Disease drug, Aricept, may improve memory in patients with Multiple Sclerosis brain fog. Help MS patients to meet the cognitive challenges of their daily lives.
In a Neurology editorial, P. Murali Doraiswamy, MD, of Duke University Medical Center and Stephen Rao, PhD, of the Medical College of Wisconsin, agree. Praising Krupp’s study as “a major advance,”
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.